Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation.
Yoshida S, Ara T, Okada K, Mori Y, Tsukamoto S, Miyashita N, Kasahara K, Ebata K, Iwasaki J, Takahashi S, Shigematsu A, Minauchi K, Kobayashi N, Ogasawara M, Imamura M, Teshima T, Ota S. Yoshida S, et al. Among authors: miyashita n. Bone Marrow Transplant. 2023 Jan;58(1):97-99. doi: 10.1038/s41409-022-01843-y. Epub 2022 Oct 15. Bone Marrow Transplant. 2023. PMID: 36243759 Free PMC article. No abstract available.
Successful salvage treatment with antithymocyte globulin for patients with early-onset hemophagocytic lymphohistiocytosis refractory to steroid and etoposide therapy following allogeneic hematopoietic stem cell transplantation.
Kakinoki Y, Ishio T, Kimura H, Shimono J, Miyashita N, Sekine T, Kasahara K. Kakinoki Y, et al. Among authors: miyashita n. Bone Marrow Transplant. 2020 Jul;55(7):1479-1482. doi: 10.1038/s41409-020-0802-z. Epub 2020 Jan 28. Bone Marrow Transplant. 2020. PMID: 31992843 No abstract available.
[Bing-Neel syndrome successfully treated with tirabrutinib].
Yokoyama K, Ohigashi H, Miyajima T, Miyashita N, Okada S, Hasegawa Y, Sugita J, Onozawa M, Hashimoto D, Teshima T. Yokoyama K, et al. Among authors: miyashita n. Rinsho Ketsueki. 2022;63(8):870-875. doi: 10.11406/rinketsu.63.870. Rinsho Ketsueki. 2022. PMID: 36058857 Japanese.
Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia.
Yoshida S, Onozawa M, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Hirabayashi S, Mori A, Hidaka D, Minauchi K, Shigematsu A, Hashiguchi J, Igarashi T, Kakinoki Y, Tsutsumi Y, Ibata M, Kobayashi H, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Ota S, Kondo T, Teshima T. Yoshida S, et al. Among authors: miyashita n. Int J Hematol. 2023 Apr;117(4):544-552. doi: 10.1007/s12185-022-03522-6. Epub 2022 Dec 26. Int J Hematol. 2023. PMID: 36572814 Free article.
Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study.
Miyashita N, Onozawa M, Yoshida S, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Hirabayashi S, Fujisawa S, Mori A, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Nagashima T, Ibata M, Wakasa K, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Kondo T, Teshima T. Miyashita N, et al. Int J Hematol. 2023 Jul;118(1):36-46. doi: 10.1007/s12185-023-03567-1. Epub 2023 Feb 28. Int J Hematol. 2023. PMID: 36853451
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis.
Yokoyama S, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Matsukawa T, Goto H, Fujisawa S, Miki K, Hidaka D, Hashiguchi J, Wakasa K, Ibata M, Takeda Y, Shigematsu A, Fujimoto K, Tsutsumi Y, Mori A, Ishihara T, Kakinoki Y, Kondo T, Hashimoto D, Teshima T. Yokoyama S, et al. Among authors: miyashita n. Br J Haematol. 2023 Jun;201(6):1144-1152. doi: 10.1111/bjh.18800. Epub 2023 Apr 17. Br J Haematol. 2023. PMID: 37067758
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, Okada S, Chen X, Kikuchi R, Miyashita N, Onozawa M, Goto H, Endo T, Hasegawa Y, Ohigashi H, Ara T, Hasegawa Y, Murakami M, Teshima T, Hashimoto D. Senjo H, et al. Among authors: miyashita n. Blood. 2023 Aug 3;142(5):477-492. doi: 10.1182/blood.2023019875. Blood. 2023. PMID: 37216687
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
Miyajima T, Onozawa M, Yoshida S, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Goto H, Sugita J, Fujisawa S, Hidaka D, Ogasawara R, Mori A, Matsuoka S, Shigematsu A, Wakasa K, Kasahara I, Saga T, Hashiguchi J, Takeda Y, Ibata M, Yutaka T, Fujimoto K, Kondo T, Teshima T. Miyajima T, et al. Among authors: miyashita n. Eur J Haematol. 2023 Oct;111(4):620-627. doi: 10.1111/ejh.14055. Epub 2023 Jul 19. Eur J Haematol. 2023. PMID: 37465857
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia.
Kimura H, Onozawa M, Yoshida S, Miyashita N, Yokoyama S, Matsukawa T, Hirabayashi S, Goto H, Endo T, Oguri S, Fujisawa S, Mori A, Kondo T, Hidaka D, Okada K, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Hashiguchi J, Nagashima T, Ibata M, Wakasa K, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Teshima T. Kimura H, et al. Among authors: miyashita n. Ann Hematol. 2023 Nov;102(11):3103-3113. doi: 10.1007/s00277-023-05405-0. Epub 2023 Aug 19. Ann Hematol. 2023. PMID: 37597110
496 results